Induction of eryptosis by low concentrations of E. coli alpha-hemolysin by Carrizo Velásquez, Fernanda et al.
Biochimica et Biophysica Acta 1848 (2015) 2779–2788
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemInduction of eryptosis by low concentrations of E. coli alpha-hemolysinFernanda Carrizo Velásquez a, Sabina Maté a, Laura Bakás b, Vanesa Herlax a,⁎
a Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CCT-La Plata, CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120, 1900 La Plata, Argentina
b Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, 47 y 115, 1900 La Plata, ArgentinaAbbreviations: HlyA, alpha hemolysin; PS,
sphingomyelinase; PC, phosphatidylcholine; SM, sphingo
⁎ Corresponding author at: INIBIOLP, Facultad de Cien
Plata, Argentina.
E-mail address: vherlax@med.unlp.edu.ar (V. Herlax).
http://dx.doi.org/10.1016/j.bbamem.2015.08.012
0005-2736/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 18 May 2015
Received in revised form 6 August 2015
Accepted 18 August 2015
Available online 21 August 2015
Keywords:
RTX toxin
Eryptosis
μ-Calpains
Endogenous sphingomyelinase
CytoskeletonUropathogenic strains of Escherichia coli deliver the toxin alpha-hemolysin (HlyA) to optimize the host environ-
ment for the spread of infection. It was reported that at high concentrations, the toxin forms pores in eukaryotic
membranes, leading to cell lysis, while lower concentrations have appeared to interfere with host–cell-signaling
pathways causing cell death by apoptosis. Nevertheless, what is not clear is how often HlyA reaches levels that
are high enough to lyse host target cells during the course of an infection. In the present investigation, we dem-
onstrate that a low toxin concentration induces the suicidal death of erythrocytes (eryptosis), themajor cell type
present in blood. Eryptosis is triggered both by an increment in intracellular calcium and by ceramide. Since we
have previously demonstrated that a low concentration of HlyA induces an increase in intraerythrocyte calcium,
in the present experiments we have shown that this ion activates calpains, which hydrolyze skeleton proteins
such as spectrin, ankyrin, protein 4.1 and the electrophoretic Band-3 species, thus resulting in morphologic
changes in the erythrocytes. We furthermore observed that a low toxin concentration induced the activation
of endogenous sphingomyelinases that in turn increased the amount of ceramide in erythrocyte membranes.
Both spectrin proteolysis and ceramide formation may cause the exposure of phosphatidylserine on the mem-
brane so as to trigger a macrophage engulfment of the erythrocyte. By this means eryptosis may be an advanta-
geous mechanism for removing defective erythrocytes before hemolysis.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Alpha hemolysin (HlyA)—themajor virulence factor of uropathogenic
Escherichia coli strains—causes 50% of all extraintestinal infections in
humans [1,2]. During the last years, HlyA has been considered the proto-
type of a large family of pore-forming toxins, denoted as RTX [3,4].
The pore-forming toxins—besides their cytotoxic activity—can trig-
ger cellular responses that may produce serious long-term effects in
host organism. Many of these responses are triggered by an uncon-
trolled flux of calcium across the plasma membrane. The influx of this
ion has been studied in several types of cells treated with HlyA [5–7].
With respect to erythrocytes treated with HlyA, Skals et al. demonstrat-
ed that the ATP leakage and Ca2+ influxes caused by the insertion of
HlyA into membranes, activate purinergic receptors and pannexin
channels [8]. This activation further potentiates the influx of extracellu-
lar Ca+2 and contributes to the shrinkage and crenation of erythrocytes
resulting from the activation of calcium-dependent K+ channels
(Gardos channels) and the Cl− channel TMEM16A [9]. Recently, we
were able to quantify the intracellular calcium concentration ofphosphatidylserine; SMase,
myelin.
cias Médicas, 60 y 120, 1900 Laerythrocytes by fluorescence lifetime-imaging microscopy, using
phasor representation [10]. We demonstrated that in rabbit erythro-
cytes the interaction with HlyA causes a fourfold increase in intracellu-
lar calcium before the occurrence of hemolysis.
In recent years, Skals et al. introduced the idea of how autocrine
and/or paracrine signaling and the cell's intrinsic volume regulation
markedly influence the fate of erythrocytes after HlyA membrane
insertion [8,9,11]. For many years, erythrocytes had been thought to
be simply membranous hemoglobin-containing vesicles floating in the
circulation. In the last decade, studies on calcium homeostasis in
erythrocytes have increased since the discovery that a small rise in
intraerythrocyte calcium triggers apoptosis (eryptosis) despite the ab-
sence of organelles such as nuclei and mitochondria. The most recent
studies disclosed that increased cytosolic Ca2+ activity and ceramide
both trigger eryptosis, a process characterized by the exposure of
phosphatidylserine (PS) on the erythrocyte surface. Erythrocytes with
PS exposed in this manner may be engulfed by macrophages or may
adhere to vascular endothelial [12].
In nucleated cells, caspases are essential mediators of apoptosis; in
contrast, in erythrocytes μ-calpain is the protease responsible for induc-
ing the cleavage of several membrane proteins to produce morphologic
alterations such as cell shrinkage [13–15]. Calpains are calcium-
dependent cysteine proteases that exist constitutively as inactive pro-
enzymes. By the increment of cytosolic calcium, calpain translocates
from the cytosol to the erythrocyte membrane, where it undergoes
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mainly transmembrane or membrane-associated proteins including
the plasma-membrane Ca2+ pump and the proteins constituting elec-
trophoretic bands 1 and 2 (the α and β spectrins, respectively) plus
bands 2.1, 3, 4.1, and 4.2, in addition to calpain itself [17,14]. Calpastatin
is the natural regulator of the enzyme's activity in erythrocytes. Its inter-
action with calpain is also Ca2+ sensitive [16].
On the basis of all these results, in the present work we studied the
effect of HlyA on calpain activation and ceramide formation in erythro-
cytes and accordingly demonstrated that a low concentration of HlyA
induces eryptosis.
2. Experimental procedures
2.1. Materials
HlyA was purified from culture filtrates of the E. coli strain WAM
1824 [18] that was kindly provided by Dr. R. A. Welch, University of
Wisconsin, Madison, USA. Calpain inhibitor II (A6060), monoclonal
anticeramide antibodies (C8104-50TST), and FITC-labeled goat anti
(mouse IgG) antibodies (F2653) were purchased from Sigma Chemical
Co. (MO, USA). The Ringer buffer (pH 7.4) contained (in mM): 125
NaCl, 5 KCl, 1 MgSO4, 32 HEPES, 5 glucose, and 1 CaCl2.
2.2. Erythrocyte preparation
Human erythrocytes were isolated from the defibrinated venous
blood of healthy volunteers, who gave the appropriate informed
consent. The total erythrocyte population was separated from the
other blood components by centrifugation at 2000 g for 15 min at
20 °C. After three washings with 0.9% (w/v) NaCl by centrifugation at
2000 g for 5 min, the packed cells were resuspended in Alsever's
solution (Sigma Chemical Co., USA) for storage at 4 °C for no more
than two days.
2.3. Protein purification
E. coli HlyA was purified from culture filtrates of the overproducing
strain WAM 1824. Cultures were grown in Luria–Bertani medium to
late log phase to an absorbance of 0.8–1.0 at 600 nm (A600), the cells
pelleted, and the toxin in the supernatant concentrated and partially
purified by precipitation with 20% (v/v) cold aqueous ethanol at
pH 4.5, the toxin's pI. The pellet containing the toxin was collected by
centrifugation (1 h, 14,500 g in a Sorvall centrifuge, rotor SSA 34) and
then resuspended in TC buffer (20 mM Tris, 150 mM NaCl, pH 7.4)
supplemented with 6 M guanidinium hydrochloride. Sodium-
dodecylsulfate-polyacrylamide-gel electrophoresis (SDS-PAGE) of this
preparation showed a main band at 110 kDa corresponding to more
than 90% of the total protein (Supplementary Fig. S1). Small proteins
were removed by molecular dialysis (membrane cutoff, 30 kDa). The
resulting proteinswere stored at−70 °C in guanidinium hydrochloride
and were dialyzed in TC buffer (1:100 v/v) at 4 °C for 4 h before use in
each experiment.
2.4. Hemolytic assays
Hemolysis was determined by measuring light scattering at 595 nm
of a humanerythrocyte suspension. The proteinswere serially diluted in
Ringer's buffer in a 96-well microtiter plate.
Of the diluted suspensions, 100 μl weremixedwith 100 μl of 5% (v/v)
erythrocytes in Ringer's buffer. The platewas then incubated at 37 °C for
30 min and the absorbance at 595 nm measured with a Multimode
Detector DTX 880 Beckman Coulter.
The percent hemolysis was calculated at 30 min by Eq. (1):
%hemolysis ¼ ODc–ODxð Þ  100= ODc–ODTxð Þ ð1Þwhere ODC is the optical density of the control erythrocytes, ODx is the
optical density of the erythrocytes treatedwith different concentrations
of toxin, and ODTx is the optical density of erythrocytes after the
addition of Triton X-100.
The D50 was defined as the amount of HlyA needed to produce a 50%
lysis of the erythrocyte suspension.
2.5. Calpain activity
The calpain assay involves the hydrolysis of whole casein molecules
by members of the calpain family and the subsequent detection at
280 nm of trichloroacetic-acid–soluble casein peptides [19]: 800 μl of
assay buffer (100 mM Tris–acetate [pH 7.5], 100 mM KCl, 500 μM
CaCl2 [for μ-calpain], 5 mM dithiothreitol, 5 mg/ml casein) was added
to 200 μl of cell suspension (hematocrit 5% after treatment with 3.5
and 7.0 pM HlyA for 5 and 15 min at 37 °C) and the mixture incubated
for 30 min at 25 °C, followed by the addition of 800 μl of ice-cold 5%
(v/v) trichloroacetic acid to stop the reaction. Then, the mixture was
centrifuged at 4000 g for 10 min and the absorbance of the supernatant
measured at 280 nm. The controls samples were prepared by mixing
800 μl of control buffer (the assay buffer with 10mM ethylenediamine-
tetraacetic acid replacing the CaCl2), 800 μl of ice-cold trichloroacetic
acid, and 200 μl of cell suspension, sequentially without incubation.
The enzyme activity was obtained by subtracting the absorbance of
the control sample from that of the test samples.
2.6. Lipid-dot-blot assay
One ,microliter of each lipid was spotted onto nitrocellulose
membranes (GE Healthcare) from a 1mM stock solution in chloroform.
Themembranes were left to dry at room temperature for 1 h in order to
evaporate all the solvent; next blocked for 2 h in TBS buffer (10 mM
Tris–HCl, 150 mM NaCl, pH 7.4); then washed five times in TBS buffer,
each time for 5 min; and finally incubated with mouse anticeramide
antibodies in 3% (v/v) skim milk in TBS buffer (1:100) for 1 h. The
membranes were then washed with TBS buffer and incubated with
secondary goat antimouse antibodies conjugated with fluorescein
isothiocyanate (goat antimouse IgG-FITC; 1:500) for 30 min. Finally,
the membranes were washed once again with TBS buffer as above and
the fluorescence measured in a STORM 840 Molecular Imager.
2.7. Determination of ceramide formation
The activation of endogenous sphingomyelinases (SMases) was
determined by measuring ceramide formation in time by an immuno-
fluorescence assay. Erythrocytes (0.1% (v/v) were incubated with
3.5 pM of HlyA at 37 °C for 2, 5, 10 and 15 min. Samples were
centrifugated at 6000 rpm, the supernatant was separated to measure
hemoglobin release by spectroscopy at 412 nm and erythrocytes were
fixed with 1% (v/v) glutaraldehyde/Ringer buffer (20 min, 4 °C), and fi-
nally pelleted onto coverlips coated with 0.001% v/v poly-L-lysine
(200 g, 5 min, 20 °C). After three washes with Ringer's buffer the cells
were exposed to mouse anticeramide antibodies (1:5) followed by
goat antimouse IgG-FITC (1:20). Fluorescence images were captured
with an Olympus DP70 digital camera attached to an Olympus BX51
microscope with an excitation of 460–495 nm (emission filter
510–550 nm). An objective of 100× with a NA of 1.35 was used.
Captured images were exported to an image analysis program (ImageJ)
for their analysis.
2.8. SDS-PAGE of ghost erythrocytes treated with HlyA
Human erythrocytes (4 ml of a 5% [v/v] solution) were incubated
with different concentrations of HlyA (3.5, 7.0, and 1000 pM) for
30 min at 37 °C. Then the samples were centrifuged at 14,500 g for
10 min and the erythrocytes osmotically lysed in 10 mM Tris–HCl,
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centrifugation during 10 min at 14,500 g, and washed by centrifuging
in the same buffer until the supernatant remained clear. Themembrane
proteins were quantified by the method of Bradford [20]. Finally, 20 μg
of proteins were separated by SDS-PAGE on a 5–20% (w/v) gradient
gel. Proteins were stained with Coomassie blue R-250 and the band
intensity quantified by means of the software Image-J.
2.9. Mass spectrometric analysis
Gel slices from bands A, B, C and D, derived from different experi-
mental conditions: control, 7 pM and 1 nM HlyA, were in gel-digested
with trypsin. Tryptic peptides were separated using an EASY-nLC 1000
LC system (Thermo Scientific). Samples were loaded at a constant
flow of 300 nl/min onto an EASY-Spray Column (C18, 2 μm, 100A,
50 μm × 150 mm) (Thermo Scientific). After trap enrichment peptides
were eluted with a linear gradient from 5–50% solvent B (acetonitrile
with 0.1% formic acid) over 45 min with a constant flow of 300
nl/min. The EASY nLC system was coupled to an Orbitrap Q Exactive
(Thermo Scientific). Full scan MS survey spectra (m/z 400–2000) in
profile mode, were acquired in the Orbitrap with a resolution of
70,000 after accumulation of 3 e6 ions. The ten most intense peptide
ions from the preview scan were fragmented by Higher-Energy
Collisional Dissociation (Activation type: HCD, Normalized collision
energy: 27%, Isolation width: 3 m/z) after accumulation of 50,000 ions
and analyzed in the Orbitrap at 7500 resolution. Maximal filling times
were 100 ms for the FT-MS full scans and 120 ms for the FT-MS/MS
scans.
Protein identification and quantitation was performed using
Proteome Discoverer (Version 1.4.1.14) with Sequest HT database
searching against the Uniprot Homo sapiens database. Mass tolerance
for peptide precursors was set at 5 ppm with fragment mass tolerance
set at 0.02 Da. Enzyme specificity was set to trypsin with a maximum
of two missed cleavages. Two modifications were considered: fixed
carbamidomethylation of cystein and variable oxidation of methionine.
False Discovery Rate was set to 1% with a minimum of two high confi-
dence peptides for quantitation.
2.10. Statistical analysis
A Student's t-testwas used for statistical comparisons among groups
and differences were considered statistically significant when P b 0.05
(*P b 0.05, **P b 0.01, ***P b 0.001).Fig. 1.Hemolytic activity of alpha-hemolysin. Panel A: hemolysis kineticswasmeasured as the d
Curves a, b, and c correspond to 14, 7.0, and 3.5 pM alpha-hemolysin, respectively. In the figure
the toxin in sec on the abscissa. The arrow indicates the following increasing concentrations of to
blue1.1× 10−10M, pink5×10−11M, light blue 2.8× 10−11M, gray1.4× 10−11M, brown7×1
B: this is a representative curve of three independent experiments where the percent hemolysi
lysin concentration on the abscissa.3. Results
3.1. HlyA hemolytic activity
The purpose of the assay was to determine the toxin concentration
to use in subsequent experiments, with an aim at working in sublytic
concentrations. Fig. 1, Panel A shows the hemolysis kinetics of human-
erythrocyte suspensions exposed to increasing molar concentrations
of toxin. As expected, the hemolysis was greater and faster as the
toxin levels increased. Fig. 1, Panel B indicates the percent hemolysis
calculated at 30 min over a wide range of toxin concentrations. Since
the HlyA concentration producing 50% erythrocyte lysis was
9.54 × 10−12 M (9.5 pM), further experiments were performed at
toxin concentrations below this level. The hemolysis–kinetics curve at
this toxin concentration should fall between curves a and b of Fig. 1,
Panel A, which loci correspond to 1.4 × 10−11 M (14 pM) and
7 × 10−12 M (7.0 pM) of HlyA, respectively.
3.2. Ceramide formation in erythrocytes treated with HlyA
Suicidal erythrocyte death or eryptosis is characterized by cell
shrinkage, membrane blebbing, and the exposure of PS on the cell sur-
face. The signaling of eryptosis also involves activation of SMase with
the formation of ceramide [21]; which sphingolipid, in combination
with Ca2+, stimulates cell-membrane scrambling. Ca2+ further acti-
vates Gardos channels, which are Ca2+-sensitive K+ channels, leading
to cellular K+ loss and cell shrinkage. Calcium also activates calpains,
resulting in a degradation of the cytoskeleton [22,23]. Some of these
characteristics were previously reported by Skals et al., for erythrocytes
treated with sublytic concentrations of HlyA [9,11].
Since increased cytosolic-Ca+2 concentrations and ceramide both
trigger eryptosis, we studied the formation of that sphingolipid in
HlyA-treated erythrocytes by immunofluorescence. In order to ensure
we were working at sublytic concentration, we followed the hemolysis
process by optical microscopy during 15 min at different toxin concen-
tration below 9.5 pM. Figs. 2 and 3, Panel A show that within the first
15 min, 3.5 pM of HlyA does not produce hemolysis, although an in-
creased of crenated erythrocytes is observed at 2 min of toxin interac-
tion (Fig. 3, Panel A). The volume of erythrocytes treated with HlyA,
most notably, decreased, as a result of an activation of the K+ channels
by Ca2+, as had been reported previously by Skals et al. [9]. The lack of
hemolysis during HlyA–erythrocyte incubation is also shown in Fig. 3,
Panel B. This figure shows that the amount of hemoglobin measure in
supernatant is the same in presence or absence of HlyA, suggestingecrease in turbidity of an erythrocyte suspension treatedwith increasing amounts of toxin.
, the absorbance of the suspension at 595 nm is plotted as a function of time of exposure to
xin: black 1.8 × 10−9M, red 9 × 10−10M, light green 4.5× 10−10M, yellow 2.2 × 10−10M,
0−12M, dark green 3.5×10−12M, dark blue1.7 ×10−12M, and green 8.7 ×10−13M. Panel
s calculated at 30 min on the ordinate is expressed as a function of the molar alpha-hemo-
Fig. 2. Ceramide formation in erythrocytes treated with alpha-hemolysin. Erythrocytes (0.1% (v/v) were incubated with 3.5 pM of HlyA at 37 °C for 2, 5, 10 and 15 min. Samples were
centrifugated at 6000 rpm, and the remaining cells were fixedwith 1% (v/v) glutaraldehyde/Ringer's buffer and pelleted onto coverlips coatedwith 0.001% v/v poly-L-lysine. Panel A: cer-
amide formation on the erythrocyte-cell surfacewas determined by immunofluorescence. Fixed treated erythrocyteswere then exposed tomouse anticeramide antibodies (1:5) followed
by FITC-labeled goat anti(mouse IgG) antibodies (1:20). Both images of fluorescence and optical microscopy are shown for control and HlyA-treated erythrocytes. Images were captured
with an Olympus DP70 digital camera attached to an Olympus BX51microscope with an excitation of 460–495 nm (emission filter 510–550 nm). An objective of 100× with a NA of 1.35
was used. Panel B: captured images were analyzed using the Image J software. The fluorescence intensity of each cell wasmeasured. The figure shows the ratio between the fluorescence
intensity of each cell with the fluorescence of the background subtracted and the corresponding difference of untreated cells. Results show the fluorescence mean value of five images
taken at each time of three independent experiments (**P b 0.01, ***P b 0.001). Panel C: 1.5 nmol of 1,2-dioleoyl-glycero-3-phosphocholine (DOPC), sphingomyelin (SM), and ceramide
(CER) was spotted on nitrocellulose membranes. The membranes were then blocked as described in Experimental procedures section and were analyzed by immunoblotting with poly-
clonal anticeramide and FITC-labeled goat anti(mouse IgG) antibodies. Dot blots were developed by chemiluminescence. An equal volume was spotted for each lipid concentration
assayed.
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tion during the experiment. The inset figure shows that the number of
cells and the crenated ones keep constant during the experimentsFig. 3.Cells andhemoglobin quantification. Panel A: erythrocytes (0.1% (v/v))were incubatedw
and the remaining cells were fixedwith 1% (v/v) glutaraldehyde/TC buffer and pelleted onto co
tant was separated to measure hemoglobin release by spectroscopy at 412 nm. Hemoglobin rel
incubated in buffer during the same period of time. Inset: Cells quantification (total and crenat
counting of five images taken at each time of three independent experiments (***P b 0.001).when HlyA is not added. This clearly demonstrates that the increment
of crenated cells observed in Fig. 3 is due toxin interaction. So consider-
ing that 3.5 pM of HlyA does not produce hemolysis during 15 min, theith 3.5 pMof HlyA at 37 °C for 2, 5, 10 and 15min. Sampleswere centrifugated at 6000 rpm,
verlips coated with 0.001% v/v poly-L-lysine, for their quantification. Panel B: the superna-
ease was also measured in samples of erythrocytes without HlyA treatment but that were
ed cells) of untreated erythrocytes at 0 and 20 min. All results show themean value of the
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this condition. Fig. 2, Panel A shows the microscopy images obtained
at 2, 5, 10 and 15 min. It can be seen that fluorescence intensity of the
erythrocyte membranes increased considerably relative to that of the
control erythrocytes. This difference is clearly shown in Fig. 2, Panel B
obtained from different cells in five images captured at each time. The
control assay of untreated erythrocytes at 15 min incubated with
anticeramide antibody shows a very slight fluorescence (Fig. 2, panel
A). On the other hand, erythrocytes treated only with goat antimouse
IgG-FITC antibody lacked any fluorescence (data not shown). Fig. 2,
Panel C shows that the anticeramide antibody interacted specifically
with ceramide but not with either phosphatidylcholine (PC) or
sphingomyelin (SM), the two main phospholipids of the outer bilayer
of human erythrocytes [24]. On the basis of these results we were
reassured that HlyA induced the activation of endogenous SMases
with the subsequent formation of ceramide.3.3. Calpain activation
In order to obtain a more complete understanding of the effects on
erythrocytes produced by low concentrations of HlyA, we measured
the calpain activity in cells treated with the toxin.
Calpains are ubiquitous calcium-dependent cysteine proteases that
selectively cleave proteins in the presence of calcium. Human erythro-
cytes contain only calpain I (the μ-calpain), and that enzyme's activity
is regulated by the endogenous inhibitor calpastatin [25].
Fig. 4 shows the calpain activity of erythrocytes treated with in-
creased concentrations (1.8, 3.5 and 7.0 pM) of HlyA at 5 and 15 min.
The calpain activity increased with time upon exposure of erythrocytes
to HlyA, in a concentration-dependent manner. The differences ob-
served in calpain activity at 15min are significant compared to untreat-
ed erythrocytes. The reason for the slight differences observed between
calpain activity at 3.5 and 7.0 pMHlyA, might be attributable to the very
similar hemolysis observed at these two concentrations by 15 min., as
illustrated by curves b and c of Fig. 1, Panel A. For further experiments
we will use 7.0 pM of HlyA to be certain of working at sublytic levels
of HlyA and be sure that calpains were activated.Fig. 4. Calpain activation induced by alpha-hemolysin. Calpain activity measured as the
detection of trichloroacetic-acid–soluble peptide fragments from casein through absor-
bance at 280 nm. A suspension of 5% (v/v) erythrocytes was first preincubated with 1.8,
3.5 and 7.0 pM alpha-hemolysin for 5 and 15min. Then the calpain activity wasmeasured
in the cell suspensions as described in Experimental procedures section. As a positive con-
trol of calpain activity, the assay was also performed on cells pretreated with 1 μM
ionomycin, a calcium ionophore, for 15 min; while as a negative control the erythrocytes
were incubatedwith the calpain inhibitor II (20 μM) before the addition of alpha-hemoly-
sin. *P b 0.05. n = 3. In the figure, the absorbance at 280 nm is plotted for each of the ex-
perimental groups shown on the abscissa.3.4. Target proteins of calpains within the erythrocyte membranes
The structural organization of the erythrocyte membrane enables it
to suffer reversible deformationwhilemaintaining its structural integri-
ty during its 4-month period of circulation. A notable feature of those
induced erythrocyte deformations is that they involve no significant
change in the membrane's surface area. These unusual membrane
properties are the result of the interaction between the 2-dimensional
elastic network of cytoskeletal proteins with cytoplasmic domains of
transmembrane proteins embedded in the plasma-membrane [26].
Transmembrane or membrane-associated proteins including the
plasma-membrane Ca+2 pump and cytoskeletal proteins such as the
electrophoretic protein bands 1, 2 (theα and β spectrins, respectively),
2.1, 3, 4.1, and 4.2 are the main targets of activated calpains [17].
Fig. 5, Panel A shows the electrophoretic profile of erythrocyte
membranes treated with increasing concentrations of HlyA. A marked
decrease in a protein band named B, corresponding to a MW of
90 kDa approximately, is apparent even at low concentration of HlyA
(7.0 pM) and becomes less intense at the increased HlyA concentration
(1 nM). A similar decrease is also observed for both bands named A. At
first glance, to obtain the data for Fig. 5, Panel B we first calculated the
optical density (OD) ratio between each of the two protein bands and
the actin band (band C)—the latter being a protein that is not cleaved
by calpain. The OD value calculated for Band A corresponded to that of
both bands combined that are shown in the gel (Fig. 5, Panel A). We
then expressed these respective OD ratios as a fraction value of the
corresponding bands in the control sample not exposed to HlyA, with
that value being set at 1.0. In the figure the data expressed in this way
indicate that both bands, A and B, decreased significantly as theFig. 5. Target proteins of calpainswithin the erythrocytemembranes. Panel A: electropho-
retic profiles obtained from erythrocytes treated with alpha-hemolysin. The asterisk indi-
cates the appearance of a band at ca. 40 kDa. Panel B: densitometric analyses were
performed by the 1D Image Analysis software (ImageJ). To calculate the decrease in the
Band B (black bars) and Band A (gray bars) content in alpha-hemolysin-treated erythro-
cytes, the optical density (OD) value corresponding to each of the two bands was
expressed as a ratio relative to the OD value for the actin band. In each of 6 independent
experiments (n = 6) the ratio of that relative value for a given protein in each of the ex-
perimental groups indicated on the abscissa to that of the corresponding protein in the
control sample, set at a value of 1.0, was calculated and plotted on the ordinate.
**P b 0.01, ***P b 0.001.
Table 2
The PSM of each protein in the bands studied in control and HlyA-treated erythrocytes.
Band A Band B Band C
α-Spectrin
0 pM HlyA 560 218 81
7 pM HlyA 630 152 511
1 nM HlyA 248 20 40
β-Spectrin
0 pM HlyA 490 181 90
7 pM HlyA 586 112 469
1 nM HlyA 190 18 25
Ankyrin-1
0 pM HlyA 271 79 35
7 pM HlyA 313 56 246
1 nM HlyA 59 4 19
Band 3
0 pM HlyA 166 167 68
7 pM HlyA 294 103 379
1 nM HlyA 76 53 21
Protein 4.1
0 pM HlyA 16 79 35
7 pM HlyA 39 45 195
1 nM HlyA 0 0 15
Actin
0 pM HlyA 5 6 83
7 pM HlyA 8 36 11
1 nM HlyA 0 0 72
Bold numbers indicate the increment of fragmented peptides of each protein in Band C.
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calpain hydrolyzes those cytoskeleton proteins. Furthermore, a band
of ca. 40 kDa appeared upon HlyA treatment (Fig. 5, Panel A; asterisk).
Fig. 5, Panel A also shows the electrophoretic profile of erythrocyte
membranes treated with increasing amounts of HlyA, but also in the
presence of the calpain inhibitor II (lanes 4 and 6). Under this condition,
the band at 40 kDa was clearly not present, and the OD ratios corre-
sponding to Band A and B were very similar to those of the respective
bands in the untreated erythrocytes (Fig. 5, Panel B). Taken together,
these results provide convincing evidence that HlyA induces the activa-
tion of calpains, which in turn degrade specific cytoskeleton proteins.
To further investigate which of the cytoskeleton proteins were
proteolysed by calpains, gel slices of Bands A, B, C and the band corre-
sponding to 40 kDa (Band D) were carefully cut and analyzed on the
Q Exactive™ Hybrid Quadrupole-Orbitrap (Thermo Scientific) mass
spectrometer. Table 1 shows the main proteins found in bands A, B
and C of control erythrocytes.
These results indicate that Band A is composed mainly by α and β
spectrins, and in minor proportion of ankyrin and Band 3; Band B also
contains these proteins although in smaller amounts plus Protein 4.1,
and finally in Band C apart from these proteins we can find actin. The
fact that Band 3 appears not only in Band B, at its expected molecular
mass, but also at high proportion in BandAmight be due to the presence
of dimers of this protein that were not denatured by the SDS present in
the loading buffer [27].
Taking profit that the peptide spectrummatches parameter (PSM), a
scoring function that measures the “matching” quality between a spec-
trum and a peptide, is proportional to the amount of peptides identified
for a certain hit and therefore proportional to the amount of protein in
the studied sample, we summarize in Table 2 the PSM found for each
hit in each band in control and treated-erythrocytes with 7 and 1 nM
of HlyA.
From the analysis of data presented in Table 2we can observe thatα,
β spectrins and ankyrin-1 are mainly concentrated in Band A and that
their amount decreases significantly upon 1 nM HlyA treatment. Addi-
tionally, it can be seen that in erythrocytes treated with 7 pM of HlyA,
a great amount of these protein is found in Band C (highlighted num-
bers). Taking into account that Band C comes from a molecular mass
range of around 40 kDa, the increment of PSM for these proteins at
this MW can only be explained by their proteolysis. The same effect is
observed for protein 4.1, with the difference that this protein is concen-
trated in Band B in the control experiment. On the other hand, it is dif-
ficult to assign the presence of Band 3 in Band A or B, but if we
consider the MW of the monomer we can propose that Band 3 is con-
centrated in Band B. In this case we can also observe a decrease in its
amount with HlyA concentration, and the increment of fragmented
peptides of this protein in Band C. Instead, actin, which is concentratedTable 1
Protein identification in each studied band.
Band Accession no. Description
A P02549 Spectrin alpha chain, erythroc
P11277 Spectrin beta chain, erythrocy
P16157-16 Isoform Er15 of Ankyrin-1 OS
P02730 Band 3 anion transport protein
B P02549 Spectrin alpha chain, erythroc
P11277 Spectrin beta chain, erythrocy
P02730 Band 3 anion transport protein
P16157-10 Isoform Er3 of Ankyrin-1 OS =
P11171-3 Isoform 3 of Protein 4.1 OS =
C P02549 Spectrin alpha chain, erythroc
P11277 Spectrin beta chain, erythrocy
P02730 Band 3 anion transport protein
P60709 Actin, cytoplasmic 1 OS = Homin Band C, does not decrease significantly with HlyA treatment as the
other proteins. It is import to mention that actin in erythrocytes treated
with 7 pMof HlyA is distributed between B and C, probably due to tech-
nical reasons of the way the band was cut from the gel. The decrease of
proteins amount is shown in Fig. 6.
Table 3 shows the proteins found in Band D, the bandwhich is made
apparent in the gel at around 40 kDa only upon HlyA treatment (Fig. 5,
Panel A).
The PSM for each protein shows that at 7 pM of HlyA in at around
40 kDa (Band D) there is a coelution of fragments of α and β spectrins,
ankyrin, prot 4.1 and Band 3, with actin; but when erythrocytes are
treated with lytic concentration of HlyA, only fragments of Band 3 are
found in this band.
The data used for the analysis presented can be seen in the Supple-
mentary files SF1, SF2, SF3 and SF4, corresponding to Band A, B, C and
D analysis, respectively.
On the basis of these results, we can conclude that at low concentra-
tion (7 pM) HlyA activates calpains that degradates α and β spectrins,Score MW (kDa)
ytic 1 OS = Homo sapiens 1511.46 279.8
tic OS = Homo sapiens 1285.04 246.3
= Homo sapiens 702.56 203.3
OS = Homo sapiens 378.13 101.7
ytic 1 OS = Homo sapiens 517.03 279.8
tic OS = Homo sapiens 443.88 246.3
OS = Homo sapiens 320.81 101.7
Homo sapiens 186.43 197.6
Homo sapiens 188.48 93.2
ytic 1 OS = Homo sapiens 175.90 279.8
tic OS = Homo sapiens 179.40 246.3
OS = Homo sapiens 115.91 101.7
o sapiens 183.09 41.7
Fig. 6.PSMof eachprotein. The PSMofα andβ spectrin, ankyrin, band 3, prot 4.1 and actin
was graphed for control and treated erythrocytes with 7 and 1 nM of HlyA.
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mately, but at higher toxin concentration the peptides generated are
smaller.4. Discussion
Uropathogenic E. coli strains find an extremely nutrient-poor host
environment; that was the reason why it was primarily thought that
the function of HlyA was to lyse host cells, thereby facilitating the
release of nutrients and other substances that are critical for bacterial
growth. Nevertheless, what is not clear is how often HlyA reaches levels
that are high enough to lyse host target cells during the course of an
infection. In fact, sublytic concentrations of HlyA may be even more
physiologically relevant within such a scenario. Indeed, recent studies
have demonstrated that sublytic concentrations of a number of
pore-forming toxins canmodulate a variety of host signaling pathways;
including the transient stimulation of calcium oscillations, an activation
of the mitogen-activated-protein-kinase signaling, and an alteration of
the histone-phosphorylation and -acetylation patterns [28,29]. In
addition, sublytic concentrations of HlyA have been recently found to
potently stimulate the inactivation of protein kinase B, a key enzyme
in host cell-cycle progression, metabolism, vesicular trafficking, surviv-
al, and inflammatory-signaling pathways [30]. In this work we further
investigated the effects induced by low concentrations of HlyA in eryth-
rocytes, the major cell type present in blood.
We observed that the hemolysis increased with elevated HlyA
concentrations (Fig. 1, Panel B), while the kinetics of the process also
changed at progressively higher levels of the toxin (Fig. 1, Panel A). At
HlyA concentrations higher than the D50, changes in the OD with time
display a cooperative behavior, with a short lag period occurring beforeTable 3
The PSM of each protein in Band D in control and HlyA-treated erythrocytes.
Band D Band D
α-Spectrin Band 3
7 pM HlyA 77 7 pM HlyA 30
1 nM HlyA 0 1 nM HlyA 7
β-Spectrin Protein 4.1
7 pM HlyA 69 7 pM HlyA 11
1 nM HlyA 0 1 nM HlyA 0
Ankyrin-1 Actin
7 pM HlyA 41 7 pM HlyA 55
1 nM HlyA 0 1 nM HlyA 0erythrocyte hemolysis. This interval diminished as the toxin concentra-
tion increased. At toxin concentrations below the D50 (i.e., 9.5 pM),
however, this cooperativity disappeared and theODdiminished directly
and linearly with time (Fig. 1, Panel A). This shift indicated that the
mechanism of erythrocyte lysis at high and low levels of toxin is differ-
ent. The cooperativity at high toxin concentration has been associated
with an oligomeric pore formation [31,32]. These observations raised
the question as to what happens in erythrocytes interacting with toxin
concentrations that are low because of dilution in the blood andwheth-
er or not such erythrocytes would lyse in the same way.
In order to answer these questions, we studied the effects induced
by low concentrations of HlyA in erythrocytes as a simulation of the
dilute situation within the circulation. Recently, López et al. have
demonstrated that SMase activity increases because of an increment
in the membrane-bending energy [33]. This observation prompted us
to study the possibility of an activation of SMase resulting from changes
in the membrane-bending energy subsequent to an insertion of the
toxin into the membrane. Whether erythrocytes contain a neutral [33]
or an acid [21] SMase is still not clear; but both enzymes catalyze the
production of ceramide from the SM present in the outer layer of the
membrane, with the difference in their action being only the pH opti-
mum for catalysis [34]. Figs. 2 and 3 illustrate that the ceramide concen-
tration increases in erythrocytes treated with a low concentration of
toxin after 15 min. Ceramide is a sphingolipid that has gained much at-
tention as a key signalingmolecule in vital cell processes—e.g., eryptosis
[21]. This role is mainly attributable to the ceramide chemical structure,
whose geometry induces changes in the biophysical properties ofmem-
branes. The tight cohesive interactions between ceramide molecules
leads phase separation of ceramide-rich and -poor microdomains [35],
thus generating defects in the interfaces. This form of interaction
might explain the lag phase and gradual hemolysis observed at low
concentrations of HlyA (Fig. 1).
In a previous publication we demonstrated that the intracellular
calcium concentration increased from 60 nM up to 150 nM before the
onset of hemolysis when erythrocytes had been in contact with the
toxin [10]. Since calpains ubiquitously are calcium-dependent cysteine
proteases that selectively cleave proteins in response to calcium, we
were prompted to study the activation of these proteases within the
context of the action of HlyA. Human erythrocytes contain only calpain
I (the μ-calpain), whose activity is regulated by the endogenous inhibi-
tor calpastatin [25]. Fig. 4 demonstrates that calpain activity increases
when erythrocytes are treated with an extremely low HlyA concentra-
tion (3.5 pM). Although mature erythrocytes contain caspases, those
enzymes were seen to remain inactive, with calpains being the prote-
ases that were activated in response to elevated calcium levels [15] to
further induce events precipitating eryptosis—namely the proteolysis
of membrane and transmembrane proteins, such as spectrins, ankyrin,
Band 3 and protein 4.1 (Figs. 5 and 6), so as to modify the erythrocyte
shape and produce cell shrinkage. HlyA-treated erythrocytes exhibit a
reduction of these proteins levels and a putative cleavage product of
the latter at 40 kDa (Fig. 6). This band is not visible in the presence of
the calpain inhibitor II, thus confirming that HlyA induces authentic
calpain activation. Furthermore, De Franceschi et al. suggested that
calpain I is involved in enhancing Gardos-channel activity [36]. Accord-
ingly, because calpain I modulates the activity of the membrane-
transport systems involved in the regulation of erythrocyte hydration
and therefore shape, we can state that the shrinkage of erythrocytes
treatedwith HlyA that was both observed by Skals et al. [9] and demon-
strated in these present experiments (Fig. 3) was caused by the activa-
tion of calpains and that the proteolysis by these enzymes activated the
Gardos channel to destabilize the erythrocyte cytoskeleton. Berg et al.
demonstrated that the calpain inhibitor prevented spectrin degradation
by calpain, as we have likewise shown in this work (Fig. 5, Panel B), and
also forestalled erythrocyte shrinkage; but the exposure of PS remained
unaffected [15]. Thus the exposure of this phospholipid in erythrocytes
treated with HlyA [9] might result from a flip-flop lipid movement
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of SMase [33] that in turn was caused by an HlyA-induced increment
in membrane-bending energy.
The normal biconcave human erythrocyte possesses a 40% greater
surface area than a sphere of the same volume (90 fL), giving the cell
the property to deform. The maintenance of erythrocyte shape is medi-
ated by a strong cohesion between the bilayer and the membrane skel-
eton, preventing membrane vesiculation and membrane breakup. Of
the various linkages that have been documented, those mediated by
Band 3 appear to be the dominant determinants of that membraneFig. 7. Summary of the effect produced by acohesiveness [26]. This role of Band 3might explain the change in eryth-
rocyte shape uponHlyA treatment (Fig. 2).Weobserved that the activa-
tion of calpains induced the proteolyses of Band 3 (Fig. 5), and that
cleavage might favor the formation of microvesicles that, in turn, pro-
duce a reduction in erythrocyte volume. The increase in ceramide in
the membrane also facilitates the budding of vesicles [37], though that
phenomenon needs to be further investigated.
In view of all these results together, we can conclude that at low
toxin concentrations erythrocytes undergo a series of biochemical and
morphologic changes provoked by a calcium influx that induces alow concentration of alpha-hemolysin.
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duced by the insertion of the toxin into the membrane activates
SMasewith a consequentmodification of themembrane-lipid composi-
tion that, for its part, participates in a synergic effect on the structure
and properties of themembrane. Both calcium and ceramide are second
messengers in the induction of eryptosis. Thus, through this concatena-
tion of effects, HlyA at low concentrations induces the eryptosis of dam-
aged erythrocytes in vivo, as summarized in the model depicted in
Fig. 7. In this figure glycophorin A (GPA) was introduced because it
was characterized as receptor for HlyA in erythrocytes [38]. Further in-
vestigation is needed to clarify if its interaction with the toxin might af-
fect its participation in the complex of attachment of the membrane to
the cytoskeleton. In vivo, suicidal erythrocyte death accomplishes the
clearance of defective red cells before hemolysis. The presence of PS
on the erythrocyte surface promotes the adherence of eryptotic cells
to the endothelial elements and also promotes erythrocyte phagocyto-
sis and intracellular degradation by macrophages. In contrast, in vitro,
the biophysical changes in the erythrocytemembrane at low toxin con-
centrations result in only a gradual hemolysis.
Unlikewith other pore-forming toxins, the putative pores formed by
HlyA and related toxins have still not been observed—not even by
electron microscopy, crystal-structure determination, atomic-force mi-
croscopy, or other imaging techniques. That despite the high molecular
mass of this toxin the direct visualization of such a pore has not yet been
possible is indeed remarkable. Rather, the pore-forming capacity of
HlyA has always been determined indirectly by osmotic protection
and electrophysiological experiments [4,39–41]. Perhaps such a pore-
like structure does not exist and the cytolytic effects observed result
from several signals triggered by the interaction of HlyA with the
membrane.
This figure shows a summary of the results present in this
manuscript. The first panel shows the structure of the main complexes
(ankyrin and 4.1R complexes) involve in the interaction between the
membrane and the cytoskeleton network. Our results demonstrate
that low toxin concentrations induce a series of biochemical and
morphologic changes of erythrocytes provoked by a calcium influx
that induces a proteolytic activation of calpain. Moreover, the mechan-
ical stress produced by the insertion of the toxin into themembrane ac-
tivates SMase with a consequent modification of the membrane-lipid
composition that, for its part, participates in a synergic effect on the
structure and properties of the membrane (mid panel). Both calcium
and ceramide are second messengers in the induction of eryptosis
(last panel). Thus, through this concatenation of effects, HlyA at low
concentrations induces the eryptosis of damaged erythrocytes in vivo,
which accomplishes the clearance of defective red cells before hemoly-
sis. In contrast, in vitro, the biophysical changes in the erythrocyte
membrane at low toxin concentrations result in only a gradual
hemolysis.5. Concluding remarks
In the present work we demonstrate that in human erythrocytes
HlyA induces activations of both endogenous calpains and SMases to
effect morphologic changes that result from both a destabilization
of the cytoskeleton and a cleavage of proteins involved in the regula-
tion of the erythrocyte volume and shape. These alterations precipi-
tate the eryptosis of damaged erythrocytes. By this means eryptosis
can function as a useful mechanism to remove defective erythrocytes
before hemolysis. Nevertheless, excessive eryptosis can lead to
anemia—if an accelerated eryptosis cannot be compensated by a
corresponding increase in erythropoeisis—and thus diminish
microcirculation, through the adherence of PS-exposed erythrocytes
to the vascularwall. In addition, since erythrocyteswith exposed PS also
stimulate blood clotting [42], excessive eryptosis could also lead to
thrombosis.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2015.08.012.
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